The Fgl2 prothrombinase contributes to the pathological process of experimental pulmonary hypertension.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of applied physiology"
DOI: 10.1152/japplphysiol.00396.2019
Abstract: In situ thrombus formation is one of the major pathological features of pulmonary hypertension (PH). The mechanism of in situ thrombosis has not been clearly identified. Fgl2 prothrombinase is an immune coagulant that can cleave… read more here.
Keywords: fgl2; fgl2 prothrombinase; situ thrombus; pulmonary hypertension ... See more keywords